Science & Medicine

A newly constructed center for studying and treating diseases of the brain will open in San Antonio at the end of the year. The Center for Brain Health could revolutionize how we understand disorders like Alzheimer's, Parkinson's, and ALS.

A digital tool that uses artificial intelligence to analyze speech patterns could help doctors detect dementia in patients when other signs and symptoms are not perceptible.

A San Antonio collaborative is developing treatments for antibiotic-resistant infections using viruses known as phages. The effort is urgent as infections that don't respond to antibiotics are projected to kill 39 million people by 2050.

Blood flow restriction ahead of surgery could be key.

A San Antonio researcher hopes to dispel myths about who is at risk for eating disorders while studying the interaction between binge eating disorder and food insecurity in older Hispanic women.

David Morilak, PhD, a professor of pharmacology and director of the Center for Biomedical Neuroscience at UT Health San Antonio, studies rats in an effort to understand the characteristics of stressful events that can lead to PTSD in humans.

A cutting-edge technology and an exciting recent hire hint at exciting developments in the future of precision medicine in the diagnosis and treatment of Alzheimer's disease.

Adam Salmon, PhD, studies aging in marmosets. He and his team recently concluded that an immunosuppressant called rapamycin extends the lifespan of marmosets. This has significant implications for the study of aging in humans.

A medication that appears to preserve brain function after a stroke will soon go into human trials. The San Antonio researcher who discovered the medication's potential more than two decades ago is still leading the team.

People with concussions get checked out pretty thoroughly by their doctors, but for some, there are cognitive changes and deficits that doctors don’t pick up.